PRagmatic Study Of Messaging to Providers of Patients With Heart Failure in Amsterdam UMC - Trial NCT06344910
Access comprehensive clinical trial information for NCT06344910 through Pure Global AI's free database. This phase not specified trial is sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) and is currently Not yet recruiting. The study focuses on Heart Failure With Reduced Ejection Fraction. Target enrollment is 900 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Best practice alert for the notification of patients with HFrEF and recommended evidence-based therapies
Observational
other
Sponsor & Location
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Timeline & Enrollment
N/A
May 01, 2024
Dec 01, 2025
Primary Outcome
Use of guideline-directed medical therapy (GDMT)
Summary
This is a prospective cohort study, where we aim to investigate the effect of implementation
 of an electronic nudge alerting clinicians to the prescription of the 4 key pharmacological
 classes for the treatment of patients with heart failure and reduced ejection fraction
 (HFrEF) at the outpatient clinic in the Netherlands.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06344910
Non-Device Trial